methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating
- RxCUI
- 2001566
- RxNorm name
- methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating
- Display name
- methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating
- Full name
- methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:21
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Lannett Company, Inc. | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | 2001566 |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Bryant Ranch Prepack | cd2c1226-fa19-4734-b62d-89fea73dcb0d | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | 2001566 |
| Methylphenidate Hydrochloride Extended-Release | METHYLPHENIDATE HYDROCHLORIDE | SpecGx LLC | b1b0f2ff-d9df-42ab-b471-226ecf97e075 | 2024-09-01 | Boxed warning, Warnings, Adverse reactions | 2001566 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| cd2c1226-fa19-4734-b62d-89fea73dcb0d | methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating | PSN | 102 | These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, USP for oral use CII Initial U.S. Approval: 2000 | 20260317 |
| cd2c1226-fa19-4734-b62d-89fea73dcb0d | BX Rating 24 HR methylphenidate hydrochloride 36 MG Extended Release Oral Tablet | SCD | 102 | These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, USP for oral use CII Initial U.S. Approval: 2000 | 20260317 |
| cd2c1226-fa19-4734-b62d-89fea73dcb0d | methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating | SY | 102 | These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, USP for oral use CII Initial U.S. Approval: 2000 | 20260317 |
| b1b0f2ff-d9df-42ab-b471-226ecf97e075 | methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating | PSN | 34 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20240901 |
| b1b0f2ff-d9df-42ab-b471-226ecf97e075 | methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating | SY | 34 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20240901 |
| b1b0f2ff-d9df-42ab-b471-226ecf97e075 | BX Rating 24 HR methylphenidate hydrochloride 36 MG Extended Release Oral Tablet | SCD | 34 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20240901 |
| 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating | SY | 32 | These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20260501 |
| 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | BX Rating 24 HR methylphenidate hydrochloride 36 MG Extended Release Oral Tablet | SCD | 32 | These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20260501 |
| 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating | PSN | 32 | These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20260501 |